ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $216,000 | -79.4% | 15,354 | -65.9% | 0.02% | -83.2% |
| Q4 2021 | $1,050,000 | -8.8% | 44,980 | -4.7% | 0.11% | -4.5% |
| Q2 2021 | $1,151,000 | +93.4% | 47,189 | +284.1% | 0.11% | +62.3% |
| Q2 2020 | $595,000 | -32.5% | 12,285 | -40.4% | 0.07% | -19.8% |
| Q4 2019 | $881,000 | -46.9% | 20,601 | -55.3% | 0.09% | -33.3% |
| Q3 2019 | $1,660,000 | +230.0% | 46,114 | +146.2% | 0.13% | +360.7% |
| Q1 2019 | $503,000 | +35.2% | 18,727 | -18.5% | 0.03% | +40.0% |
| Q4 2018 | $372,000 | – | 22,975 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |